Our process
Skyphos is enabling fast, accurate medical device prototyping by harnessing the precision and capabilities of 3D printing technology.
3D printing on the microscale.
3D printing has eclipsed a number of major manufacturing areas, and its disruptive nature has the ability to deliver excellent results. But until recently, 3D printing technology has not been feasible at high speeds or feature sizes below 100 μm.
Skyphos has pushed 3D printing capability
into the microscale by:
Achieving pixel size while maintaining build area.
We work with a pixel aspect ranging from single microns and up — enabling features below 10μm and voids or channels down to 30μm — while maintaining a build area large enough for devices.Achieving transparent biocompatibility.
One of the main hurdles of applying 3D printing to microbiology has been acquiring resins that are both biocompatible and allow optically clear devices. With the Gillespie Algorithms™, Skyphos can achieve below 200 nanometer surface roughness for all exposed areas, transparent devices that maintain low auto-fluorescence and enable cell tagging for microscopy work.Achieving minimal feature sizes.
By developing and implementing superior pixel control, Skyphos can operate at minimal features sizes with smooth internal channels.Achieving high-speed production.
Our printing speeds allow for manufacturing at high volumes and compete against fabrication techniques like injection molding and hot embossing.Achieving a prototype that is identical to the final product.
Skyphos eliminates re-testing, recalibrating, and redesign that often happens between prototype and final product when moving to hot embossing and injection molding.
